Your browser doesn't support javascript.
loading
A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions.
Shabet, Christina; Kattapuram, Meera; Burton, Anna; Thoeny, Renata; Nielsen, Hailey; Accardo, Marie Louise; Smith, Emily H; Koeppe, Erika; Else, Tobias; Cha, Kelly B.
Afiliación
  • Shabet C; University of Michigan Medical School, Ann Arbor, MI, USA.
  • Kattapuram M; University of Michigan Medical School, Ann Arbor, MI, USA.
  • Burton A; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Thoeny R; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Nielsen H; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Accardo ML; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Smith EH; Michigan Medicine Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
  • Koeppe E; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Else T; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Cha KB; Michigan Medicine Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. telse@med.umich.edu.
Fam Cancer ; 23(4): 543-550, 2024 Nov.
Article en En | MEDLINE | ID: mdl-38822938
ABSTRACT

BACKGROUND:

Birt-Hogg-Dubé (BHD) syndrome is a genetic condition caused by pathogenic variants in the FLCN gene resulting in benign skin lesions, spontaneous pneumothorax, and increased risk for a variety of renal tumors. Skin manifestations of BHD include trichodiscoma (TD) and fibrofolliculoma (FF), which may represent the same pathologic entity. These lesions can identify BHD patients, who upon positive genetic testing can be considered for life-long surveillance for renal neoplasms.

OBJECTIVE:

To characterize patients diagnosed with TD and FF including rates and outcomes of genetics referral.

METHODS:

Retrospective chart reviews of patients with confirmed or possible diagnosis of TD or FF at the University of Michigan from September 2002 through October 2020 to assess pathologic findings, personal and family history of BHD manifestations, referral for genetic evaluation, and genetic testing results.

RESULTS:

64 patients had a pathologic diagnosis of TD or FF, 16 of whom (25%) were referred to cancer genetics. Fourteen patients completed genetic evaluation, 9 of whom were diagnosed with BHD (64%), with 6 unique pathogenic variants in FLCN.

CONCLUSION:

Providers should consider referral for genetic evaluation for patients with biopsy-proven TD or FF, as early diagnosis of BHD provides the opportunity for early detection and treatment of other BHD-associated conditions.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derivación y Consulta / Neoplasias Cutáneas / Pruebas Genéticas / Proteínas Supresoras de Tumor / Síndrome de Birt-Hogg-Dubé Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derivación y Consulta / Neoplasias Cutáneas / Pruebas Genéticas / Proteínas Supresoras de Tumor / Síndrome de Birt-Hogg-Dubé Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos